Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Steele, Andrew D ^a,b   Neuzil, Kathleen M ^a   Cunliffe, Nigel A ^c   Madhi, Shabir A ^d,e   Bos, Pieter ^f   Ngwira, Bagrey ^g   Witte, Desiree ^c,g   Todd, Stacy ^c   Louw, Cheryl ^h   Kirsten, Mari ⁱ   Aspinall, Sanet ^j   Van Doorn, Leen J ^k   Bouckenooghe, Alain ^l,m   Suryakiran, Pemmaraju V ^m   Han, Htay H ^m  

^a PATH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF LIMPOPO   (South Africa)

^g UNIVERSITY OF MALAWI   (Malawi)

^h Madibeng Centre for Research   (South Africa)

ⁱ UNIVERSITY OF PRETORIA   (South Africa)

^j Synexus Clinical Research SA/Rota Consortium   (South Africa)

^k DDL Diagnostic Laboratory   (Netherlands)

^l Sanofi Pasteur ^*  (Singapore)

^m GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; INFANT; MALAWI; MULTICENTER STUDY; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; RANDOMIZED CONTROLLED TRIAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTION; SOUTH AFRICA; VIRAL GASTROENTERITIS; VIRUS STRAIN;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; INFANT; MALAWI; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOUTH AFRICA; VACCINATION; VACCINES, ATTENUATED;

EID: 84866140456     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-213     Document Type: Article

References (45)

1. World Health Organization Rotavirus vaccines. Wkly Epidemiol Rec 2007, 82:285-296. World Health Organization.
2. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200:S9-S15. 10.1086/605025, 19817620.
3. World Health Organization Rotavirus vaccination. Wkly Epidemiol Rec 2009, 84:213-236. World Health Organization.
4. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362:289-298. 10.1056/NEJMoa0904797, 20107214.
5. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):606-614. 10.1016/S0140-6736(10)60889-6, 20692030.
6. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):615-623. 10.1016/S0140-6736(10)60755-6, 20692031.
7. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22. 10.1056/NEJMoa052434, 16394298.
8. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33. 10.1056/NEJMoa052664, 16394299.
9. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763. 10.1016/S0140-6736(07)61744-9, 18037080.
10. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008, 371:1181-1189. 10.1016/S0140-6736(08)60524-3, 18395579.
11. Phua KB, Lim FS, Lau YL, Nelson EAS, Huang LM, Quak SH, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study. Vaccine 2009, 27:5936-5941. 10.1016/j.vaccine.2009.07.098, 19679216.
12. De Vos B, Han HH, Bouckenooghe A, Debrus S, Gillard P, Ward R, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009, 28:261-266. 10.1097/INF.0b013e3181907177, 19289978.
13. Offit PA, Clark HF, Blavat G, Greenberg HB. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol 1986, 60(2):491-496. 288917, 3021983.
14. Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005, 192(Suppl 1):S146-S159.
15. Kirkwood CD, Boniface K, Bogdanovic-Sakran N, Masendycz P, Barnes GL, Bishop RF. Rotavirus strain surveillance-an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine 2009, 27(Suppl 5):F102-F107.
16. Page NA, Steele AD. Antigenic and genetic characterization of serotype G2 human rotavirus strains from South Africa from 1984 to 1998. J Med Virol 2004, 72(2):320-327. 10.1002/jmv.10571, 14695677.
17. Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, Woods PA, Bresee JS, et al. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999, 57(3):308-312. 10.1002/(SICI)1096-9071(199903)57:3<308::AID-JMV15>3.0.CO;2-B, 10022804.
18. Fischer TK, Page NA, Griffin DD, Eugen-Olsen J, Pedersen AG, Valentiner-Branth P, et al. Characterization of incompletely typed rotavirus strains from Guinea-Bissau: identification of G8 and G9 types and a high frequency of mixed infections. Virology 2003, 311(1):125-133. 10.1016/S0042-6822(03)00153-3, 12832210.
19. Steele AD, Nimzing L, Peenze I, de Beer MC, Geyer A, Angyo I, Gomwalk NE. Circulation of the novel G9 and G8 rotaviruses in Nigeria in 1998/1999. J Med Virol 2002, 67:608-612. 10.1002/jmv.10146, 12116012.
20. Esona MD, Geyer A, Page N, Trabelsi A, Fodha I, Aminu M, et al. Genomic characterization of human rotavirus G8 strains from the African rotavirus network: relationship to animal rotaviruses. J Med Virol 2009, 81(5):937-951. 10.1002/jmv.21468, 19319943.
21. Page N, Esona M, Seheri M, Nyangao J, Bos P, Mwenda J, et al. Characterization of genotype G8 strains from Malawi, Kenya, and South Africa. J Med Virol 2010, 82(12):2073-2081. 10.1002/jmv.21912, 20981795.
22. Gouvea V, de Castro L, Timenetsky MC, Greenberg H, Santos N. Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol 1994, 32(5):1408-1409. 263717, 8051281.
23. Gómara MI, Kang G, Mammen A, Jana AK, Abraham M, Desselberger U, et al. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol 2004, 42:2541-2547. 10.1128/JCM.42.6.2541-2547.2004, 427862, 15184432.
24. Cunliffe NA, Ngwira BM, Dove W, Nakagomi O, Nakagomi T, Perez A, et al. Serotype G12 rotaviruses, Lilongwe, Malawi. Emerg Infect Dis 2009, 15:87-90. 10.3201/eid1501.080427, 2660691, 19116060.
25. Page NA, de Beer MC, Seheri LM, Dewar JB, Steele AD. The detection and molecular characterization of human G12 genotypes in South Africa. J Med Virol 2009, 81:106-113. 10.1002/jmv.21362, 19031449.
26. Iturriza-Gómara M, Green J, Brown DW, Desselberger U, Gray JJ. Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol 2000, 38(2):898-901. 86240, 10655412.
27. Esona MD, Steele D, Kerin T, Armah G, Peenze I, Geyer A, et al. Determination of the G and P types of previously nontypeable rotavirus strains from the African Rotavirus Network, 1996-2004: Identification of unusual G types. J Infect Dis 2010, 202(Suppl):49-54.
28. Steele AD, Ivanoff B. Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. Vaccine 2003, 21:361-367. 10.1016/S0264-410X(02)00616-3, 12531633.
29. Sanchez-Padilla E, Grais RF, Guerin PJ, Steele AD, Burny ME, Luquero FJ, et al. Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:567-576. 10.1016/S1473-3099(09)70179-3, 19695493.
30. Todd S, Page NA, Steele AD, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis 2010, 202(Suppl):S34-S42.
31. O'Ryan M. Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines 2007, 6:11-19. 10.1586/14760584.6.1.11, 17280473.
32. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrheal episodes. Scand J Infect Dis 1990, 22:259-267. 10.3109/00365549009027046, 2371542.
33. van Doorn LJ, Kleter B, Hoefnagel E, Stainier I, Poliszczak A, Colau B, et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J Clin Microbiol 2009, 47:2704-2712. 10.1128/JCM.00378-09, 2738096, 19553575.
34. Neuzil KM, Armah GE, Parashar UD, Steele AD. Rotavirus in Africa: shifting the focus to disease prevention. J Infect Dis 2010, 202(Suppl):S1-S4.
35. Mwenda JM, Ntoto KM, Abebe A, Enweronu-Laryea C, Amina I, Mchomvu J, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis 2010, 202(Suppl):S5-S11.
36. Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis 2009, 200(Suppl 1):S28-S38.
37. WHO, UNICEF, World Bank State of the world's vaccines and immunization 2009, Geneva: World Health Organization, 3, WHO, UNICEF, World Bank.
38. Cunliffe NA, Gondwe JS, Graham SM, Thindwa BD, Dove W, Broadhead RL, et al. Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol 2001, 39(3):836-843. 10.1128/JCM.39.3.836-843.2001, 87838, 11230392.
39. Armah GE, Steele AD, Binka FN, Esona MD, Asmah RH, Anto F, et al. Changing patterns of rotavirus genotypes in Ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Microbiol 2003, 41(6):2317-2322. 10.1128/JCM.41.6.2317-2322.2003, 156506, 12791843.
40. Steele AD, Peenze I, de Beer MC, Pager CT, Yeats J, Potgieter N, et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine 2003, 21:354-360. 10.1016/S0264-410X(02)00615-1, 12531632.
41. Gray J, Vesikari T, Van Damme P, Giaquinto C, Mrukowicz J, Guarino A, et al. Rotavirus. J Pediatr Gastroenterol Nutr 2008, 46:S24-S31. 10.1097/MPG.0b013e31816f78ee, 18460969.
42. Flores J, Perez-Schael I, Blanco M, Vilar M, Garcia D, Perez M, et al. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J Clin Microbiol 1989, 27(3):512-518. 267349, 2541168.
43. Ward RL, Knowlton DR, Schiff GM, Hoshino Y, Greenberg HB. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol 1988, 62(5):1543-1549. 253180, 3357205.
44. Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003, 16(1):17-24. 10.1089/088282403763635410, 12725685.
45. Cunliffe NA, Ngwira BM, Dove W, Thindwa BD, Turner AM, Broadhead RL, et al. Epidemiology of rotavirus infection in children in Blantyre, Malawi, 1997-2007. J Infect Dis 2010, 202(Suppl):S168-S174.